Impact of reporting rules of biopsy Gleason score for prostate cancer

Journal of Clinical Pathology

Volumn 62, Issue 3, 2009, Pages 260-263

  Kuroiwa, K ^a   Uchino, H ^a   Yokomizo, A ^a   Naito, S ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 61849159901     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.060632     Document Type: Article

References (21)

1. Montironi R, Mazzucchelli R, Scarpelli M, et al. Prostate carcinoma II: prognostic factors in prostate needle biopsies. BJU Int 2006;97:492-7.
2. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-8.
3. Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228-12.
4. Rubin MA, Bismar TA, Curtis S, et al. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol 2004;28:946-52.
5. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74.
6. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4.
7. Jhaveri FM, Klein EA, Kupelian PA, et al. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 1999;17:3167-72.
8. Albertsen PC, Hanley JA, Barrows GH, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005;97:1248- 53.
9. Chism DB, Hanlon AL, Troncoso P, et al. The Gleason score shift: score four and seven years ago. Int J Radiat Oncol Biol Phys 2003;56:1241-7.
10. Kondylis FI, Moriarty RP, Bostwick D, et al. Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias. J Urol 2003;170:1189-93.
11. Smith EB, Frierson HF Jr, Mills SE, et al. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? Cancer 2002;94:2282-7.
12. Epstein JI. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol 2000;24:477-8.
13. Pan CC, Potter SR, Partin AW, et al. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 2000;24:563-9.
14. Kunz GM Jr, Epstein JI. Should each core with prostate cancer be assigned a separate Gleason score? Hum Pathol 2003;34:911-4.
15. Poulos CK, Daggy JK, Cheng L. Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites. Mod Pathol 2005;18:228-34.
16. Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003;170:1792- 7.
17. Han M, Partin AW, Piantadosi S, et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001;166:416-9.
18. Patel AA, Chen MH, Renshaw AA, et al. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. JAMA 2007;298:1533-8.
19. Helpap B, Egevad L. Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. Anal Quant Cytol Histol 2008;30:133-8.
20. Klotz L. Active surveillance with selective delayed intervention for favorable risk prostate cancer. Urol Oncol 2006;24:46-50.
21. Makarov DV, Sanderson H, Partin AW, et al. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4+3 and 3+4 independent of the number of involved cores? J Urol 2002;167:2440-2.